Topical Solvent Composition for Erectile Dysfunction Without GTN
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for erectile dysfunction, such as those containing glyceryl trinitrate (GTN), suffer from side effects like headaches and are contraindicated for users taking nitrate-containing medications, and there is a desire for formulations without synthetic chemicals.
Innovation Solution
A composition comprising volatile and non-volatile solvents, including lower alcohols and polyhydric alcohols and glycols, without GTN, sildenafil, or acetylcholinesterase inhibitors, that enhances endogenous nitric oxide production through physical stimulation, promoting tumescence and erection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If GTN-containing compositions are used to treat erectile dysfunction, then efficacy is improved, but side effects (headaches) and contraindications increase
Solution Approach 1:
The patent removes GTN (glyceryl trinitrate) from the composition entirely, extracting the harmful nitrate component while retaining the solvent system. The composition now contains only volatile solvents (lower alcohols like ethanol/propanol and water) and non-volatile solvents (polyhydric alcohols like glycerol and glycols like propylene glycol), eliminating headaches and contraindications associated with nitrate-containing medications.
Solution Approach 2:
The composition enables the body's own physiological systems to work naturally by providing a safe environment for endogenous nitric oxide production. Instead of introducing exogenous nitrates that cause side effects, the formulation allows the penile tissue to naturally produce nitric oxide in response to stimulation, with the solvent blend optimizing this natural process.
2Reliability
If GTN-containing compositions are used, then treatment effectiveness is improved, but adaptability to users taking nitrate medications deteriorates
Solution Approach 1:
The patent extracts the nitrate component (GTN) from the formulation, making the composition compatible with users taking nitrate-containing medications for conditions like angina. The solvent-only formulation (lower alcohols, water, polyhydric alcohols, and glycols) eliminates the drug interaction risk while maintaining effectiveness through enhanced endogenous nitric oxide production.
3Reliability
If synthetic chemicals like GTN are used, then pharmacological efficacy is improved, but naturalness and safety profile deteriorate
Solution Approach 1:
The patent uses volatile solvents (lower alcohols and water) that evaporate completely after application, leaving no residual synthetic chemicals. The volatile nature of ethanol, propanol, and water ensures the composition breaks down into harmless components, aligning with natural processes and eliminating concerns about persistent synthetic chemicals in the body.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats erectile dysfunction without GTN, reducing side effects and contraindications, while maintaining efficacy comparable to GTN-containing formulations.
Implementation Method 1
the composition is to provide rapid initial absorption of GTN and an ongoing slow absorption as the volatile solvents evaporate in use so that the GTN concentration is dynamically maintained
Implementation Method 2
enhances endogenous nitric oxide production through physical stimulation, promoting tumescence and erection
Data Source
AI summary
There is provided a composition for topical application to the penis for the treatment of erectile dysfunction, the composition being free of glyceryl trinitrate (GTN), sildenafil and an acetylcholinesterase inhibitor, and comprising volatile and non-volatile solvents, the volatile solvents comprising a lower alcohol and water and the non-volatile solvents comprising a polyhydric alcohol and a glycol. Preferably, the composition does not contain any pharmaceutically active ingredients for the treatment of erectile dysfunction. Also provided is a method of determining the cooling ability of a test composition, such as the composition described above.


